Trials / Withdrawn
WithdrawnNCT06129071
Analgesic Effect of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia
Analgesic Effect Evaluation of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Varazdin General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a study about the dynamics and effects of ultrasound guided maxillary nerve block in trigeminal neuralgia
Detailed description
Standard pharmacological treatment for trigeminal neuralgia is often insufficient. In this setting, patients often suffer trough everyday activities and quality of life is disturbed substantially. In this prospective clinical study, analgesic effect of ultrasound (US) guided maxillary nerve block will be investigated, in order to prolong pain-free time, reduce the use of standard analgesics, as well as atypical ones (e.g. antiepileptic drugs and antidepressants). Characteristics of US guided maxillary nerve block will pain investigated: reduction of pain (decrease of VAS score), duration of pain-free period, pain level during the procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | US guided block of maxillary nerve | Extraoral ultrasound-guided block of the maxillary nerve will be performed in the examined group using an ultrasound device and local anesthetic levobupivacaine (0,5%, 2 mL) combined with triamcinolonacetonid (2mL). |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-12-31
- Completion
- 2025-03-01
- First posted
- 2023-11-13
- Last updated
- 2024-04-09
Locations
1 site across 1 country: Croatia
Source: ClinicalTrials.gov record NCT06129071. Inclusion in this directory is not an endorsement.